Brussels, 29/05/2006 (Agence Europe) - The Commission has approved the proposed acquisition by German company Bayer AG of the pharmaceutical company Schering AG, which is active in five global business areas: gynaecology and andrology, diagnostic imaging, specialised therapeutics, oncology and dermatology. The main overlaps are in a few over-the-counter and prescription anti-fungal markets. Bayer and Schering have their most important combined market shares (over 35%) in three of these...